| ADA | Adenosine deaminase |
| Ado | Adenosine |
| AMP | Adenosine monophosphate |
| AMPCP | A: B-Methylenadenosine 5‘ diphosphate |
| AR | Adenosine receptor |
| ATP | Adenosine triphosphate |
| BAY | BAY 60-6583 |
| ccPA | 2-chloro-N6-cyclopentyladenosine |
| CD39 | Ectonucleoside triphosphate diphosphohydrolase 1 |
| CD73 | Ecto 5′ nucleotidase |
| CGS | CGS 21680 |
| DAA | 1-Deazaadenosine |
| DAPI | 4′,6-diamidino-2-phenylindole |
| DIP | Dipyridamole |
| DMARDs | Disease-modifying antirheumatic drugs |
| ENT1 | Equilibrative Nucleoside Transporter 1 |
| ENT2 | Equilibrative Nucleoside Transporter 2 |
| FCS | Fetal calf serum |
| HEMADO | 2-(1-Hexynyl)-N-methyladenosine |
| HIF-1 | Hypoxia-inducible factor-1 |
| HPLC | High pressure liquid chromatography |
| IL-6 | Interleukin 6 |
| IL-10 | Interleukin 10 |
| Ino | Inosine |
| MMP | Matrix metalloproteinase |
| N | Number |
| n.a. | Not applicable |
| NSAID | Non-steroidal anti-inflammatory drug |
| OA | Osteoarthritis |
| PFA | Paraformaldehyde |
| RA | Rheumatoid arthritis |
| TNF | Tumor necrosis factor |
| yr | Years |